ANTIVIRAL ACTIVITIES OF PYROPHOSPHATE ANALOGUES: A NEW ANTIHERPETIC DRUG, FOSCARNETHELGSTRAND E; LERNESTEDT JO; OEBERG B et al.1981; DRUGS EXP. CLIN. RES.; ISSN 0378-6501; CHE; DA. 1981; VOL. 7; NO 3; PP. 327-330; BIBL. 14 REF.Article

Mode of interference of trisodium phosphonoformate (INN: foscarnet sodium), with influenza virus mRNA synthesisSTRIDH, S; DATEMA, R.Virology (New York, NY). 1984, Vol 135, Num 1, pp 293-296, issn 0042-6822Article

PENILE EROSIONS ASSOCIATED WITH FOSCARNET THERAPY IN A CHILDHICK, Ryan W; PROSE, Neil.Pediatric dermatology. 2010, Vol 27, Num 3, pp 302-303, issn 0736-8046, 2 p.Article

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replicationGADLER, H.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 3, pp 370-374, issn 0066-4804Article

THERAPEUTIC EFFECTS OF FOSCARNET SODIUM AND ACYCLOVIR ON CUTANEOUS INFECTIONS DUE TO HERPES SIMPLEX VIRUS TYPE 1 IN GUINEA PIGSALENIUS S; BERG M; BROBERG F et al.1982; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1982; VOL. 145; NO 4; PP. 569-573; BIBL. 15 REF.Article

Wirksamkeit und Verträglichkeit von topisch appliziertem Foscarnet-Natrium bei der Behandlung von Herpes Labialis : Ergebnisse einer Anwendungsbeobachtung = Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of post-marketing surveillanceGROSS, G; BRAUN, D.Hautarzt. 2006, Vol 57, Num 1, pp 40-46, issn 0017-8470, 7 p.Article

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)OBERG, B.Pharmacology & therapeutics (Oxford). 1982, Vol 19, Num 3, pp 387-415, issn 0163-7258Article

Crystallization After Intravitreous Foscarnet InjectionsMARTINEZ-CASTILLO, Sebastián; MARIN-LAMBIES, Cristina; GALLEGO-PINAZO, Roberto et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 5, pp 658-659, issn 0003-9950, 2 p.Article

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblastsNAESENS, Lieve; BONNAFOUS, Pascale; AGUT, Henri et al.Journal of clinical virology. 2006, Vol 37, issn 1386-6532, S69-S75, SUP1Conference Paper

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnetDREW, W. Lawrence; MINER, Richard C; MAROUSEK, Gail I et al.Journal of clinical virology. 2006, Vol 37, Num 2, pp 124-127, issn 1386-6532, 4 p.Article

Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnetTCHESNOKOV, Egor P; GILBERT, Christian; BOIVIN, Guy et al.Journal of virology. 2006, Vol 80, Num 3, pp 1440-1450, issn 0022-538X, 11 p.Article

Neue Behandlungsoption des klassischen Kaposi-Sarkoms unter Berücksichtigung aktueller Erkenntnisse zur Ätiopathogenese = Viral etiology of classic Kaposi's Sarcoma offers promising new therapeutic optionsSCHÄD, S; BALZ, C; SCHMITT-KÖPPLER, J et al.Aktuelle Dermatologie. 1998, Vol 24, Num 3, pp 56-59, issn 0340-2541Article

Is combination antiviral therapy for CMV superior to monotherapy? : CMV. Part IIIDREW, W. Lawrence.Journal of clinical virology. 2006, Vol 35, Num 4, pp 485-488, issn 1386-6532, 4 p.Article

Different mutations in the HHV 6 DNA polymerase gene accounting for resistance to foscarnetBONNAFOUS, Pascale; NAESENS, Lieve; PETRELLA, Stéphanie et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 877-888, issn 1359-6535, 12 p.Article

Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapyBESTMAN-SMITH, Julie; BOIVIN, Guy.Journal of medical virology. 2002, Vol 67, Num 1, pp 88-91, issn 0146-6615Article

Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotypeVISSE, B; HURAUX, J.-M; FILLET, A.-M et al.Journal of medical virology. 1999, Vol 59, Num 1, pp 84-90, issn 0146-6615Article

Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cellsKINI, G. D; HOSTETLER, S. E; BEADLE, J. R et al.Antiviral research. 1997, Vol 36, Num 2, pp 115-124, issn 0166-3542Article

Acute Retinal Necrosis: The Effects of Intravitreal Foscarnet and Virus Type on OutcomeWONG, Roger; PAVESIO, Carlos E; LAIDLAW, D. Alistair H et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 3, pp 556-560, issn 0161-6420, 5 p.Article

Neurovirulence and Latency of Drug-Resistant Clinical Herpes Simplex Viruses in Animal ModelsDAMBROSI, Sarah; MARTIN, Mélanie; YIM, Kevin et al.Journal of medical virology. 2010, Vol 82, Num 6, pp 1000-1006, issn 0146-6615, 7 p.Article

Synthesis and stability studies of phosphonoformate-amino acid conjugates: a new class of slowly releasing foscarnet prodrugsMARMA, Mong S; KASHEMIROV, Boris A; MCKENNA, Charles E et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 7, pp 1787-1790, issn 0960-894X, 4 p.Article

Generation of hydroxyl radicals by the antiviral compound Phosphonoformic acid (foscarnet)LINDQVIST, Christer; NORDSTRÖM, Tommy.Pharmacology & toxicology. 2001, Vol 89, Num 1, pp 49-55, issn 0901-9928Article

Foscarnet-associated eosinophilic folliculitis in a patient with AIDSROOS, Thomas C; ALBRECHT, Helmut.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 3, pp 546-547, issn 0190-9622Article

Foscarnet: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?ORDEMANN, R; NAUMANN, R; GEISSLER, G et al.Annals of hematology (Print). 2000, Vol 79, Num 8, pp 432-436, issn 0939-5555Article

Transient foscarnet-induced hypercalcaemiaBARBA, R; GOMEZ-RODRIGO, J; MARCO, J et al.AIDS (London). 1998, Vol 12, Num 14, pp 1930-1931, issn 0269-9370Article

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strainsPRIX, L; MAIERL, J; JAHN, G et al.Journal of clinical virology. 1998, Vol 11, Num 1, pp 29-37, issn 1386-6532Article